55150-393-01 : NDC 2026 Code

55150-393-01 : Azacitidine ( Azacitidine )

Additionally :

You can get information about “55150-393-01” NDC code in 55150-393-01 in HTML format

HTML | 55150-393-01 in TXT (Plain Text) format

TXT | 55150-393-01 in PDF (Portable Document Format)

PDF | 55150-393-01 in XML format

XML formats.

NDC Code : 55150-393-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "55150-393-01",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-393-01)  / 4 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "55150-0393-01",
    "ProductNDC": "55150-393",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Azacitidine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Azacitidine",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS; SUBCUTANEOUS",
    "StartMarketingDate": "20230103",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA215066",
    "LabelerName": "Eugia US LLC",
    "SubstanceName": "AZACITIDINE",
    "StrengthNumber": "100",
    "StrengthUnit": "mg/4mL",
    "Pharm_Classes": "Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-07-30",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20230103",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}